The USPSTF's expanded screening guidelines bring up important questions of screening harms and benefits, generalizing clinical trial results, and the impact of screening on health disparities. More
Health care workers in the Middle East faced the highest rates of depression and anxiety while workers in North America faced the lowest, a new study revealed. More
No one seems to have any idea how many homeless people have died, despite extraordinarily detailed statistics on the nation's Covid deaths. More
The truths that lie beneath our loneliest year. More
This analysis examines the extent to which early vaccination efforts through community health centers are reaching people of color using data from the federal government’s weekly Health Center COVID-19 Survey. More
Infusing blood plasma from people who have recovered from COVID-19 into sick patients looks good on paper. But studies of the treatment haven't found benefits. More
Few studies have examined children's enrollment in high-deductible health plans (HDHPs) and associations with health service use. We examine trends, health service use, and financial barriers to care for US children with high-deductible private insurance. More
Eliminating Covid globally means navigating a minefield of competition, limited supply, and suspicion that some vaccines aren’t as good. More
A recent report finds the pandemic has impeded the careers of women in academic science, technology, math, and medicine fields. More
The Migration Policy Institute, a nonprofit think tank in Washington, D.C., reported in January that 9.3 million unauthorized immigrants whose income meets the threshold for covid aid are blocked from accessing it, and also can’t apply for federal programs that provide cash and food assistance. More
It's time for public health officials to flip the script on vaccine equity. More
This pharmacoepidemiology study uses Medicare claims data to describe the prevalence of central nervous system–active polypharmacy among community-dwelling older adults with dementia in the US, including durations of exposure and number of drugs and drug classes. More
The pandemic has not been a story of an infection curve rising and falling, but of two lines — the haves and have-nots — moving in different directions. More
Cancer clinical trials conducted primarily outside of the United States are 2‐fold less likely to enroll Black participants than are clinical trials conducted within the United States. More
If the deal with Insight falls through and Mercy closes, the impact on its surrounding communities will be devastating. More
Pharmaceutical company researchers develop a tool to suppress the placebo effect and improve their drug results. More
Over-medication can be dangerous and patients should consult with medical professions to ensure an effective plan of treatment, Dr. Bob Newman writes in a guest column. More
In JAMA, Michael Chernew and Maximilian Pany argue that a price cap on the higher end of hospital prices would save tens of billions. More
Dr. Vivek Murthy, Biden's pick for surgeon general, was recently found to have accepted significant consulting payments from private companies. Should this disqualify him from the position? More
The shortage of lifesaving medical equipment last year was a searing example of the government’s failed coronavirus response. As health workers resorted to wearing trash bags, one Maryland company profited by selling anthrax vaccines to the country’s emergency reserve. More